Table 1.
Demographic and clinical data of patient subjects.
| Demographic data | n | Minimum | Maximum | Mean | SD | Median | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender of all patients | |||||||||||
| Male | 89 | ||||||||||
| Female | 100 | ||||||||||
| Age (years) | 193 | 22 | 89 | 65.18 | 13.95 | 68.00 | |||||
| Weight (kg) | 182 | 34 | 98 | 57.32 | 12.21 | 57.00 | |||||
|
Status of patients |
Absence |
Presence |
Opioids |
Antidep-ressant |
Anticon-vulsant |
NSAIDs† |
GABA§ |
Ketamine |
Neuro-tropin |
Lidocaine |
Others |
| Nerve block | 132 | 25 | |||||||||
| Allodynia | 75 | 30 | |||||||||
| Administration of drugs | 50 | 66 | 99 | 25 | 58 | 7 | 5 | 18 | 4 | ||
|
Diagnosis (disease status) |
|
n |
Diagnosis (disease status) |
|
|
|
n |
||||
| Postherpetic neuralgia (PHN) | 92 | Spinal canal stenosis | 20 | ||||||||
| Lower back pain (LBP) | 13 | Postoperative pain | 12 | ||||||||
| Hernia of intervertebral disk | 8 | Neck pain | 8 | ||||||||
| Others | 46 | ||||||||||
†Non-steroidal anti-inflammatory drugs.
§Gamma-aminobutyric acid receptor modulators.